The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,959.00
Bid: 1,952.00
Ask: 1,954.00
Change: 20.00 (1.03%)
Spread: 2.00 (0.102%)
Open: 1,940.00
High: 1,971.00
Low: 1,940.00
Prev. Close: 1,939.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 27th Nov 2013 09:14

Aviva: Nomura moves target price from 474p to 489p retaining a buy recommendation.Bellway: Numis upgrades to buy with a target price of 1690p.Breedon Aggregates: Jefferies starts with a target price of 42p and a buy recommendation.Britvic: UBS ups target price from 575p to 600p and keeps a neutral rating. Barclays upgrades to overweight with a target price of 690p.BTG: Deutsche Bank takes target price from 500p to 570p reiterating a buy recommendation. Panmure Gordon raises target price from 490p to 610p and retains a buy recommendation. Investec ups target price from 472p to 723p and maintains a buy recommendation.Compass Group: Numis increases target price from 850p to 900p and stays with its hold recommendation. Panmure Gordon takes target price from 820p to 900p maintaining a hold recommendation.De La Rue: Citi lowers target price from 1055p to 1000p downgrading from buy to neutral. Panmure Gordon ups target price from 786p to 806p and keeps a hold recommendation.Essar Energy: Deutsche Bank cuts target price from 175p to 75p, while maintaining a hold recommendation.Hargreaves Lansdown: Numis ups target price from 1006p to 1027p and maintains a hold recommendation.Hikma Pharmaceuticals: Goldman Sachs raises target price from 1180p to 1200p and keeps a neutral rating.IGas Energy: Canaccord Genuity shifts target price from 181p to 180p and stays with its buy recommendation.Imagination Technologies: Jefferies reduces target price from 628p to 393p, while leaving its buy recommendation unchanged.Immunodiagnostic Systems: Investec ups target price from 466p to 494p keeping a hold recommendation.Innovation Group: Panmure Gordon shifts target price from 41p to 44p and reiterates a buy recommendation.Jardine Lloyd Thompson Group: Westhouse Securities initiates with a target price of 1130p and an add rating.Marshalls: Jefferies initiates with a target price of 166p and a hold recommendation.Mitchells & Butlers: Nomura ups target price from 370p to 390p and keeps a neutral rating. JP Morgan upgrades from underweight to neutral with a target price of 400p. Panmure Gordon increases target price from 310p to 365p, but still recommends selling.MITIE Group: UBS moves target price from 305p to 320p, while downgrading from buy to neutral.Mondi: Goodbody cuts target price from 1290p to 1240p and reiterates a buy recommendation.NMC Health: Numis ups target price from 500p to 560p and reiterates a buy recommendation.Rio Tinto: Canaccord Genuity reduces target price from 4100p to 4000p, while its buy recommendation remains unchanged.Royal Mail: Investec places its target price (prev.: 544p) under review, while staying with its hold recommendation.Severn Trent: Goldman Sachs shifts target price from 2113p to 2110p, while leaving its buy recommendation unaltered.Shaftesbury: Liberum Capital takes target price from 622p to 636p and retains a hold recommendation.Smith (DS): Citi moves target price from 300p to 340p maintaining a buy recommendation. Goodbody ups target price from 285p to 295p, while downgrading to hold.Tesco: JP Morgan lowers target price from 335p to 315p and retains an underweight rating.Topps Tiles: Cantor Fitzgerald downgrades to sell with a target price of 82p.Tyman: Jefferies initiates with a target price of 269p and a buy recommendation.VP: Cantor Fitzgerald raises target price from 490p to 570p retaining a buy recommendation.
More News
22 Feb 2024 09:42

TOP NEWS: Hikma boosts dividend after year of "significant progress"

(Alliance News) - Shares in Hikma Pharmaceuticals PLC jumped on Thursday after it lifted the dividend by 29% amid better-than-expected annual profit.

Read more
22 Feb 2024 07:51

Hikma lifts dividend after double-digit growth in 2023

(Sharecast News) - Hikma Pharmaceuticals impressed the market with its annual results on Thursday as it bumped up its dividend by almost a third following double-digit growth in core revenues and profits in 2023.

Read more
15 Feb 2024 14:42

UK earnings, trading statements calendar - next 7 days

Friday 16 February 
NatWest Group PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 19 February 
Bank of Cyprus Holdings PLCFull Year Results
MoneySupermarket.com PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 20 February 
Antofagasta PLCFull Year Results
Barclays PLCFull Year Results
BHP Group LtdHalf Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Gran Tierra Energy IncFull Year Results
InterContinental Hotels Group PLCFull Year Results
Petra Diamonds LtdHalf Year Results
Springfield Properties PLCHalf Year Results
Wednesday 21 February 
BAE Systems PLCFull Year Results
Conduit Holdings LtdFull Year Results
Glencore PLCFull Year Results
HSBC Holdings PLCFull Year Results
Rio Tinto PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
Tate & Lyle PLCTrading Statement
Thursday 22 February 
Anglo American PLCFull Year Results
Genus PLCHalf Year Results
Hargreaves Lansdown PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Indivior PLCFull Year Results
Jupiter Fund Management PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
ME Group International PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
WPP PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
2 Feb 2024 07:23

Hikma agrees to settle US opioid claims

(Sharecast News) - Hikma Pharmaceuticals announced an agreement in principle to address the majority of opioid-related claims filed against it by various US states, local communities and tribal nations on Friday.

Read more
1 Feb 2024 20:00

EARNINGS AND TRADING: Tandem FY sales down 17%; Hikma's opioid deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Jan 2024 09:29

LONDON BROKER RATINGS: Berenberg cuts target prices for miners

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Wednesday:

Read more
20 Dec 2023 09:25

LONDON BROKER RATINGS: UBS cuts DS Smith; Kepler likes Genus

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
19 Dec 2023 09:11

LONDON BROKER RATINGS: Peel Hunt raises Flutter to 'buy' from 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 13:08

Jefferies downgrades Hikma to 'hold'

(Sharecast News) - Jefferies downgraded Hikma Pharmaceuticals on Tuesday to 'hold' from 'buy' and cut the price target to 1,940p from 2,125p.

Read more
7 Nov 2023 09:28

LONDON BROKER RATINGS: Watches of Switzerland impresses HSBC; Asos cut

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
7 Nov 2023 07:43

LONDON BRIEFING: AB Foods hails Primark; Beazley premiums rise

(Alliance News) - London's FTSE 100 is called to open in the red on Tuesday, following Asian equities lower, as the good feeling in equity markets after the softer US jobs data on Friday gives way to some caution.

Read more
6 Nov 2023 12:01

Berenberg stays at 'hold' on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg reiterated their 'hold' rating and 2,100.0p target price on Hikma Pharmaceuticals on Monday, saying a "lighter" second half was playing out in its injectables unit.

Read more
3 Nov 2023 09:31

LONDON BROKER RATINGS: JPMorgan lifts Smith & Nephew

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
2 Nov 2023 15:12

London close: Stocks rise as BoE keeps rates steady

(Sharecast News) - London's stock markets ended the day on a positive note on Thursday, following the Bank of England's decision to maintain interest rates as markets widely expected.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.